Clinical Edge Journal Scan

Caprylate and acetate levels in breast milk and infantile atopic dermatitis: Is there a link?


 

Key clinical point: Lower levels of caprylate and acetate in breast milk could be risk factors for infantile atopic dermatitis (AD) in exclusively breastfed infants.

Major finding: Caprylate ( P = .034) and acetate ( P = .002) levels were significantly lower in breast milk for infants with vs. without AD, with caprylate ( P = .021) and acetate ( P = .015) levels in breast milk being the factors significantly associated with the presence of infantile AD.

Study details: This prospective, observational study included 94 2- to 4-month-old exclusively breastfed infants. In this group 47 infants were diagnosed with mild (n = 17), moderate (n = 25), or severe (n = 5) AD and 47 infants without AD formed the control group.

Disclosures: This study was supported by National Taiwan University Hospital, Taipei, Taiwan. The authors declared no conflict of interests.

Source: Wang LC et al. Lower caprylate and acetate levels in the breast milk is associated with atopic dermatitis in infancy. Pediatr Allergy Immunol. 2022;33(2) e13744 (Feb 21). Doi: 10.1111/pai.13744

Recommended Reading

Patch Testing on Dupilumab: Reliable or Not?
MDedge Dermatology
Managing overuse of food IgE panels: Multiple approaches needed
MDedge Dermatology
The Impact of Prenatal Nutrition on the Development of Atopic Dermatitis in Infancy and Childhood
MDedge Dermatology
Upadacitinib shows favorable long-term benefit-risk profile in moderate-to-severe atopic dermatitis
MDedge Dermatology
Moisturizer containing urea and glycerol shows skin barrier-strengthening effects in atopic dermatitis
MDedge Dermatology
Atopic dermatitis and serum lipids: What is the link?
MDedge Dermatology
Disease severity predicts persistent sleep disturbance from atopic dermatitis
MDedge Dermatology
Age and sex determine risk for acne in patients with atopic dermatitis
MDedge Dermatology
Atopic dermatitis: Dupilumab safe and effective in real world
MDedge Dermatology
Atopic dermatitis: Patients treated with dupilumab at higher risk of developing conjunctivitis
MDedge Dermatology